Achieve Life Sciences (ACHV) Misses Q2 EPS by 64c

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($0.80), $0.64 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
• Seven Hills Realty Trust (SEVN) Reiterated at Market Outperform by Citizens Post Q2 Results